Get the Stockscreener App
43.03
2.62%
1.10
Omnicell Inc stock is traded at $43.03, with a volume of 474.93K.
It is up +2.62% in the last 24 hours and up +2.67% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$41.93
Open:
$41.91
24h Volume:
474.93K
Relative Volume:
0.78
Market Cap:
$1.96B
Revenue:
$1.23B
Net Income/Loss:
$20.43M
P/E Ratio:
97.55
EPS:
0.4411
Net Cash Flow:
$95.39M
1W Performance:
+8.85%
1M Performance:
+2.67%
6M Performance:
-4.67%
1Y Performance:
+44.40%
1-Day Range:
$41.55
$43.13
1-Week Range:
$38.53
$43.26
52-Week Range:
$26.84
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
43.03 | 1.89B | 1.23B | 20.43M | 95.39M | 0.4411 |
VEEV
Veeva Systems Inc
|
192.74 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.03 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
60.27 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
95.31 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
84.05 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-26 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-08-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Omnicell Appoints Nnamdi Njoku President, Retaining COO Role - Fort Worth Inc.
Omnicell, Inc. Announces Executive Changes - marketscreener.com
Omnicell Appoints Nnamdi Njoku as President, Stock Ticker OMCL - GuruFocus
Omnicell Promotes Nnamdi Njoku to President While Retaining COO Role - citybiz
Nnamdi Njoku appointed President of Omnicell (OMCL) while Randall Lipps remains CEO - Stock Titan
Omnicell appoints Nnamdi Njoku as president effective today By Investing.com - Investing.com Australia
Nnamdi Njoku Appointed President of Omnicell | Associated Press | syndication news - Enidnews.com
Nnamdi Njoku Appointed President of Omnicell – Company Announcement - Financial Times
Omnicell, Inc.(NasdaqGS: OMCL) added to Russell 2000 Value-Defensive Index - marketscreener.com
(OMCL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Omnicell | 4: Statement of changes in beneficial ownership of securities-Officer Manley Corey J - Moomoo
Do options traders know something about Omnicell stock we don't? - MSN
Price to sales forward of Omnicell, Inc. – NASDAQ:OMCL - TradingView
Enterprise value to EBITDA forward of Omnicell, Inc. – NASDAQ:OMCL - TradingView
Price to earnings forward of Omnicell, Inc. – MUN:OC9 - TradingView
Price to sales forward of Omnicell, Inc. – MUN:OC9 - TradingView
Omnicell, Inc. Actuals & Estimates (NASDAQ:OMCL) - TradingView
OMCL Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Omnicell, Inc. – MUN:OC9 - TradingView
How Investors May Respond To Omnicell (OMCL) Options Volatility Surge Signaling Anticipated Stock Swing - simplywall.st
Do Options Traders Know Something About Omnicell Stock We Don't? - Yahoo Finance Australia
Omnicell Inc (OMCL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Omnicell (OMCL) Stock Could Be 36.3% Undervalued After Specialty Pharmacy Leadership Hire - Sahm
Omnicell StockWeekly review and healthcare tech backdrop - AD HOC NEWS
Omnicell Inc (OMCL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Omnicell Inc (OMCL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Omnicell Inc (OMCL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Omnicell Inc (OMCL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Liquidity Mapping Around (OMCL) Price Events - Stock Traders Daily
Omnicell Inc (OMCL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Omnicell Inc (OMCL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Omnicell Inc (OMCL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Omnicell Inc (OMCL) Institutional Confidence - TradingKey
What Omnicell (OMCL)'s New Specialty Pharmacy Leader Means For Shareholders - simplywall.st
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Oric Pharmaceuticals (ORIC) and Pfizer (PFE) - The Globe and Mail
BofA Securities Maintains Omnicell(OMCL.US) With Buy Rating, Maintains Target Price $70 - Moomoo
Omnicell (NASDAQ:OMCL) Trading Down 4.9%Time to Sell? - MarketBeat
Omnicell (OMCL) is a top-ranked value stock: Should you buy? - MSN
Transcript : Omnicell, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 03 - marketscreener.com
Omnicell: Why I’m Long Into Q2 Earnings Despite The Bookings Wobble (NASDAQ:OMCL) - Seeking Alpha
Earnings Preview: Omnicell to Report Financial Results Pre-market on April 28 - Moomoo
Omnicell appoints Dan Mandoli to lead specialty pharmacy unit - Investing.com UK
Omnicell, Inc. Announces Appointment of Dan Mandoli to Senior Vice President and General Manager, Specialty Pharmacy Services - marketscreener.com
Omnicell appoints Dan Mandoli to lead specialty pharmacy unit By Investing.com - Investing.com South Africa
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business - 巴士的報
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business – Company Announcement - Financial Times
Intech Investment Management LLC Sells 30,447 Shares of Omnicell, Inc. $OMCL - MarketBeat
Omnicell (OMCL) may find a bottom soon, here's why you should buy the stock now - MSN
Omnicell Shareholders Back Governance Amendment And Long Term Growth Focus - Yahoo Finance
Should Omnicell’s (OMCL) Governance Moves and Conference Spotlight Recast Its Recurring Revenue Narrative? - Sahm
OMCL Technical Analysis & Stock Price Forecast - Intellectia AI
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Omnicell Inc Stock (OMCL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Manley Corey J | EVP&CHIEF LEGAL/ADMIN OFFICER |
May 18 '26 |
Sale |
43.22 |
5,025 |
217,180 |
112,783 |
1.79%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):